Essers
Erik Essers, Aalen DE
Patent application number | Description | Published |
---|---|---|
20090039257 | Electron beam device - An electron beam device has an electron gun for generating an electron beam, an objective lens for focusing the electron beam on an object and at least one detector for detecting electrons emitted by the object or electrons backscattered by the object. Detection of electrons emitted by or backscattered by an object may be simplified and improved using quadrupole devices and certain configurations of these devices provided in the electron beam device. | 02-12-2009 |
Franciscus Elisabeth Jacobus Essers, Maastricht NL
Patent application number | Description | Published |
---|---|---|
20110097577 | Scratch-Resistant Moulded Article Made From a Filled Polypropylene Composition - The invention relates to a moulded article made from a polypropylene composition comprising 48-94.9 mass % of a polypropylene; 5-30 mass % of glass fibres having average length of 1-50 mm; 0.1-2 mass % of oleamide and/or erucamide; and 0-20 mass % of other additives; the article showing a colour change of dL<2 in the PSA/Renault scratch tests and a colour change of dL<1.5 in the Erichsen scratch test. | 04-28-2011 |
Hans-Richard Essers, Wassenberg DE
Patent application number | Description | Published |
---|---|---|
20090081409 | TWO-DIMENSIONAL TEXTILE MATERIAL, ESPECIALLY TEXTILE FABRIC, HAVING SHRINK PROPERTIES AND PRODUCTS MANUFACTURED THEREFROM - A heat-shrinkable planar textile material with a plurality of yarn systems forming the planar textile material, wherein the planar textile material having at least one heat-shrinkable plastic yarn. The planar textile material is suitable for producing furniture elements, especially seating furniture elements, preferably backrests and/or seat elements, decorative elements, hollow channels, automotive accessories, and the like, wherein the heat-shrinkable planar textile material can be mounted on a carrier structure and then heat shrunk. | 03-26-2009 |
Heinz-Willy Essers, Wassenberg DE
Patent application number | Description | Published |
---|---|---|
20110283459 | MATTRESS, IN PARTICULAR FOR USE IN THE CARE AND HOSPITAL SECTOR - A mattress, in particular for use in the care and hospital sector, has a base layer and a top layer arranged thereon. The top layer is formed by a resilient knitted spacer fabric, which is covered by a top layer cover. The top layer cover has a liquid-impermeable top layer cover lower part and a liquid-permeable top layer cover upper part. The mattress allows simple and frequent reprocessing. | 11-24-2011 |
20120297545 | PAD, IN PARTICULAR FOR A MATTRESS IN THE NURSING CARE AND HOSPITAL SECTOR - A pad, in particular for a mattress in the nursing care and hospital sector has a liquid-impermeable and elastic lower layer and a liquid-permeable and elastic upper layer arranged on the lower layer. The lower layer and the upper layer are surrounded by an outer casing, which has a liquid-impermeable outer casing lower part facing the lower layer and a liquid-permeable outer casing upper part facing the upper layer. The pad is very comfortable to lie and/or sit on and has a high degree of breathability. Moreover, the pad is easy to clean and can accordingly be reprocessed frequently. The pad can be easily and economically retrofitted to improve the lying comfort and the breathability of existing mattresses. | 11-29-2012 |
20120324651 | PAD, IN PARTICULAR FOR USE IN THE NURSING CARE AND HOSPITAL SECTOR - A pad, in particular for use in the nursing care and hospital sector, has an elastic spacer textile, which is surrounded by an elastic foam body, a separating layer being arranged between the foam body and the spacer textile. The pad can be produced with any desired outer contour by foaming the foam body onto the spacer textile, an uncontrolled penetration of the foam body into the spacer textile and an undesired increase in the compression hardness connected therewith being avoided by the separating layer. The pad is accordingly very comfortable to sit and/or lie on. | 12-27-2012 |
20130167303 | MATTRESS WITH A SPACER TEXTILE - A mattress has a frame, which is formed from an elastic material and laterally delimits an interior. Arranged in the interior are at least two elastic spacer textiles, which are each releasable from the frame and from one another. The mattress has a high degree of reclining comfort and, because of the modular construction, can be cleaned in a conventional washing machine. | 07-04-2013 |
Jeroen Essers, Rotterdam NL
Patent application number | Description | Published |
---|---|---|
20110083199 | Non-Human Animal Model for Cardiovascular Disease Characterized by a Disrupted Fibulin-4 Gene - The invention relates to an animal model of cardiovascular disease and a method of preparation and use thereof. In particular, it relates to a genetically engineered animal model of aortic aneurysms and methods for screening drugs using the animal model. Provided is a genetically-modified, non-human mammal, wherein the modification results in a disrupted Fibulin-4 gene. Also provided is a genetically-modified animal cell containing a disrupted Fibulin-4 gene. The mammal or animal cell can be used as a model for a cardiovascular condition or disease, preferably aortic aneurysm, more preferably thoracic aortic aneurysm. Furthermore, methods for identify or validating a compound that can be used to treat or to prevent an aberrant cardiovascular condition are provided, as well as method to identify a gene involved in the response to aortic failure. | 04-07-2011 |
20120022026 | METHOD OF TREATING CANCER - The present invention relates to a method of treating or preventing hyperproliferative disease in a body tissue of a subject, comprising the steps of administering to a subject in need thereof a therapeutically effective amount of an agent that induces double strand breaks in the DNA of the hyperproliferative cells of said body tissue; and subjecting the hyperproliferative cells of said body tissue prior to, simultaneously with or subsequent to step a) to hyperthermia to thereby induce in said cells the degradation, inhibition and/or inactivation of BRCA2. | 01-26-2012 |
Marc Essers, Aachen DE
Patent application number | Description | Published |
---|---|---|
20160006138 | Method for Cohesive Joining to a Cable End, and also Configured Cable - The invention proposes a method for cohesive joining to a cable end ( | 01-07-2016 |
Marieke Essers, Pully CH
Patent application number | Description | Published |
---|---|---|
20100196320 | INTERFERON APLPHA SEQUENTIAL REGIMEN FOR TREATING CANCERS - The present invention relates to a method of treating cancers, especially those showing resistance to classical anti-pro liferative chemotherapy drugs. Further, the invention provides a specific interferon alpha sequential regimen for treating cancers, especially those showing resistance to classical anti-proliferative chemotherapy drugs such as stem cell driven cancers. More specifically, the invention relates to a use of IFN alpha for the preparation of a pharmaceutical formulation for the treatment of cancers wherein the pharmaceutical formulation is to be administered following a sequential administration pattern i.e. an induction period wherein a therapeutically effective amount of IFN alpha is administered, a period during which ni IFN alpha is administrated and a chemotherapy period wherein a therapeutically effective amount of a chemotherapeutic agent is administered. | 08-05-2010 |
Maurice Karel Hubertina Essers, Delft NL
Patent application number | Description | Published |
---|---|---|
20150111848 | GLUCAN FIBRE - Method for preparing a branched glucan having a chain comprising a plurality of glucose units linked by alpha 1,4-glycoside bonds and a plurality of side-groups linked to said chain via another type of glycoside bonding, which side-groups comprise one or more glucose units, the method comprising contacting a glucose source with a polysaccharide—which polysaccharide is a glucan comprising a plurality of glucose units linked by alpha 1,4-glycoside bonds and is essentially linear or branched to a lesser extent than the branched glucan that is to be prepared—in the presence of an acid catalyst under polycondensation conditions, thereby forming the branched glucan. | 04-23-2015 |
20150201654 | HYDROTHERMALLY MODIFIED STARCH - A process for producing thermally inhibited starch is described resulting in a viscostable starch product. The process comprises providing an alkaline starch having a pH, when measured in a 20% (w/v) aqueous dispersion, between 9.1 and 11.2, adjusting the water content of the starch to between 2 and 22 wt. %, heating the starch between 130 and 190° C., especially between 140 and 180° C., for a sufficient time and at a sufficient pressure for the inhibition of the starch to be initiated before the water content has reached a level of 1 wt. % and before the pH has reached a value of 9, continuing heating the starch between 140 and 190° C. until viscostability is achieved, and cooling and optionally further processing the starch. | 07-23-2015 |
20150274849 | RESISTANT STARCH - A colourless resistant starch is produced by a process comprising (i) suspending starch in a C2-C4 alcohol, in particular ethanol, in the presence of 0.01-3.0% (w/w) of acid based on the starch; (ii) heating the suspended starch at a temperature of 70-160° C., in particular 78-120° C., and (c) isolating the resulting product. The resulting starch has a resistant fraction of at least 20%. | 10-01-2015 |
Maurice Karel Hubertina Essers, 'S-Gravenhage NL
Patent application number | Description | Published |
---|---|---|
20150250212 | NEW FOODS WITH MODIFIED CEREAL BRAN AND METHODS FOR PRODUCING THESE - A food is modified by adding bran that has been treated with super-heated steam (SHS) to the food, or replacing the bran that already was present in the food by a cereal bran that has been treated with SHS. The SHS-treated cereal bran may or may not have undergone a pre-treatment with acid, base or water. The SHS-treated cereal bran and food products including such SHS-treated cereal bran have enhanced nutritional value. | 09-10-2015 |
Michael Essers, Bergisch Gladbach DE
Patent application number | Description | Published |
---|---|---|
20080221083 | Heterobicyclic metalloprotease inhibitors - The present invention relates generally to amide containing heterobicyclic containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-3 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13 and MMP-3 inhibitors. | 09-11-2008 |
20080221092 | Heterobicyclic metalloprotease inhibitors - The present invention relates generally to amide containing heterobicyclic containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-3 and/or MMP-13 inhibiting compounds that exhibit an increased potency and selectivity in relation to currently known MMP-13 and MMP-3 inhibitors. | 09-11-2008 |
20090312312 | Heterobicyclic Metalloprotease Inhibitors - The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors. | 12-17-2009 |
20110112051 | Dipeptidyl Peptidase-IV Inhibitors - The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes. | 05-12-2011 |
20120015920 | HETEROBICYCLIC METALLOPROTEASE INHIBITORS - The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors. | 01-19-2012 |
Michael Essers, Schoenau DE
Patent application number | Description | Published |
---|---|---|
20100009961 | DIPEPTIDYL PEPTIDASE-IV INHIBITORS - The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes. | 01-14-2010 |
Ruth Essers, Aachen DE
Patent application number | Description | Published |
---|---|---|
20140329277 | METHOD FOR CULTURING CELLS IN ORDER TO PRODUCE SUBSTANCES - The invention concerns a method for culturing cells in order to produce substances. According to the invention a cell line producing substances is cultured while feeding a nutrient medium in such a manner that glucose limitation occurs in the culture solution. The degree of glucose limitation DGL=qGlc/qGlc | 11-06-2014 |
Stefanie Essers, Berlin DE
Patent application number | Description | Published |
---|---|---|
20150258995 | Method and Assistance System for Assisting a Driver of a Motor Vehicle as well as Measuring Method and Measuring System for Determining a Mental State of a Driver of a Motor Vehicle - A method for assisting a driver of a motor vehicle is provided. The method comprises the steps: measuring at least one value of at least one vital parameter of the driver correlated with the mental state of the driver and/or at least one value of at least one driving dynamics variable correlated with the mental state of the driver, classifying the mental state of the driver with reference to the measured value of the vital parameter or the driving dynamics variable, and generating a signal perceptible by the driver by means of a driver assistance system of the motor vehicle, wherein the signal is selected from a plurality of different signals in dependence on the classification of the mental state of the driver, or suppressing a signal of the driver assistance system and/or selecting at least one vehicle parameter in dependence on the classification of the mental state. | 09-17-2015 |